We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PROC market cap is 297.86M. The company's latest EPS is USD 0.3770 and P/E is 7.00.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 110.4M | 101.47M | 84.16M | 110.06M | 118.41M |
| Operating Income | 16.64M | -3.81M | 3.3M | 34.25M | 11.92M |
| Net Income | 22.58M | 10.43M | 6.62M | 26.96M | 8.19M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 324.79M | 331.47M | 409.74M | 409.92M |
| Operating Income | 37.43M | 63.05M | 70.47M | 34.07M |
| Net Income | -17.01M | -10.45M | -100.86M | 42.54M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 471.17M | 460.19M | 441.72M | 490.72M | 498.55M |
| Total Liabilities | 481.68M | 462.07M | 436.55M | 458.7M | 460.1M |
| Total Equity | -10.51M | -1.88M | 5.17M | 32.03M | 38.45M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 337.73M | 359.54M | 462.14M | 460.19M |
| Total Liabilities | 581.68M | 614.22M | 500.48M | 462.07M |
| Total Equity | -243.95M | -254.68M | -38.34M | -1.88M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | 22.05M | 14.11M | 3.11M | 23.54M | 70.93M |
| Investing | -20.54M | -28.83M | -5.03M | -12.9M | -20.37M |
| Financing | -41.55M | -13.63M | -18.59M | -43.6M | -73.48M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 68.29M | 70.92M | 37.3M | 14.11M |
| Investing | -12.07M | -17.09M | -23.7M | -28.83M |
| Financing | -46.95M | -40.51M | 58.04M | -13.63M |
| Market Cap | 297.86M |
| Price to Earnings Ratio | 7.00 |
| Price to Sales Ratio | 0.73 |
| Price to Cash Ratio | 6.93 |
| Price to Book Ratio | -158.6 |
| Dividend Yield | - |
| Shares Outstanding | 112.82M |
| Average Volume (1 week) | 73.73k |
| Average Volume (1 Month) | 99.93k |
| 52 Week Change | -23.70% |
| 52 Week High | 4.95 |
| 52 Week Low | 0.50 |
| Spread (Intraday) | 0.12 (4.44%) |
| Company Name | Procaps Group SA |
| Address |
9, rue de bitbourg luxembourg city, luxembourg L-1273 |
| Website | https://www.procapsgroup.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
